[ORGANIZATION]
Leqembi (lecanemab)
Featured in 2 tracked stories · first seen
Situations
Leqembi Alzheimer’s drug approvals
2 clusters · 2 sources · last updated
Latest: Eisai launches Leqembi in India, introducing first disease-modifying Alzheimer’s treatment
In July 2026 the U.S. Food and Drug Administration cleared a subcutaneous, at‑home starter dose of Leqembi (lecanemab), allowing patients or caregivers to administer the first injection outside a clinic. The approval was
Also covered in
-
Swedish regulators influence Alzheimer drug dosing and anesthesia equipment use
[HEALTH] · 2 sources ·